Judith Neukirchen - Concepedia

Author

Judith Neukirchen

Heinrich Heine University Düsseldorf ORCID

Also Known As

J Neukirchen, J. Neukirchen, Judith Neukirchen

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Heinrich Heine University Düsseldorf St.-Johannes-Hospital Dortmund Hôpital Saint-Louis Radboud University Medical Center University of Freiburg

About

Judith Neukirchen is an author at Heinrich Heine University Düsseldorf specializing in medicine, hematology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	871
2	Public Health	3	3	254
3	Health Sciences	2	2	143
4	Biostatistics	1	1	36
5	Cell Biology	1	1	24

Judith Neukirchen

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Incidence and prevalence of myelodysplastic syndromes: Data from the Düsseldorf MDS-registry Judith Neukirchen, W. Marieke Schoonen, Corinna Strupp, Leukemia Research Hematological MalignancyBone Marrow FailureMyelodysplastic SyndromesAplastic AnemiaClinical Epidemiology	2011	205
The use of immunosuppressive therapy in MDS: clinical outcomes and their predictors in a large international patient cohort Maximilian Stahl, Michelle DeVeaux, Théo de Witte, Blood Advances ImmunodeficienciesImmunologyRbc TiImmunotherapyMyeloid Neoplasia	2018	129
Improved survival in MDS patients receiving iron chelation therapy – A matched pair analysis of 188 patients from the Düsseldorf MDS registry Judith Neukirchen, Frank Fox, Andrea Kündgen, Leukemia Research Prognostic EvaluationOncologyMds PatientsPrognosisClinical Trials	2012	127
Management of hyperleukocytosis and impact of leukapheresis among patients with acute myeloid leukemia (AML) on short- and long-term clinical outcomes: a large, retrospective, multicenter, international study Maximilian Stahl, Rory M. Shallis, Wei Wei, Leukemia Hematological MalignancyMedicineAcute Myeloid LeukemiaLong-term Clinical OutcomesHematology	2020	90
Refined medullary blast and white blood cell count based classification of chronic myelomonocytic leukemias Esther Schuler, M. Schroeder, Judith Neukirchen, Leukemia Research Hematological MalignancyMedicineMixed-phenotype Acute LeukemiaMalignant Blood DisorderImmunology	2014	85
Validation of the revised International Prognostic Scoring System (IPSS-R) in patients with myelodysplastic syndrome: A multicenter study Judith Neukirchen, Michael Lauseker, Sabine Blum, Leukemia Research Hematological MalignancyPrognostic AssessmentPrognostic BiomarkersMyelodysplastic SyndromePrognosis	2013	76
Platelet counts and haemorrhagic diathesis in patients with myelodysplastic syndromes Judith Neukirchen, Sabine Blum, Andrea Kuendgen, European Journal Of Haematology	2009	72
Gene expression profiling for molecular distinction and characterization of laser captured primary lung cancers Astrid Rohrbeck, Judith Neukirchen, Michael Rosskopf, Journal of Translational Medicine	2008	68
Treatment of poor-risk myelodysplastic syndromes and acute myeloid leukemia with a combination of 5-azacytidine and valproic acid A. Kuendgen, Gesine Bug, Oliver G. Ottmann, Clinical Epigenetics	2011	47
The influence of the pituitary tumor transforming gene-1 (PTTG-1) on survival of patients with small cell lung cancer and non-small cell lung cancer. Nina Rehfeld, Helene Geddert, Abedelsalam Atamna, Journal of Carcinogenesis	2006	38

Page 1